Allinaire Therapeutics Inc.
Cleveland, US · Founded 2015 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
DW
Douglas W.P. HayExecutive Officer, Director
TT
Ted TorphyManager
BS
Baiju ShahManager and Chairman
BS
Brian StemmeManager
SG
Samantha GintherDirector
SJ
Satish JindalDirector
AB
Arthur BertelsonDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$700KraisedApr 2026 · 2 investors · OtherRule 506(b)
▶$700KraisedApr 2026 · 2 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Douglas W.P. HayExecutive Officer, Director
- Satish JindalDirector
- Arthur BertelsonDirector
- Samantha GintherDirector
- Offering amount
- $700K
- Amount sold
- $700K
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedDec 2018 · 8 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedDec 2018 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Ted TorphyDirector
- Baiju ShahExecutive Officer, Director
- Brian StemmeDirector
- Offering amount
- $5M
- Amount sold
- $1.6M
- First sale
- Dec 2016
- Incorporated
- Limited Liability Company, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.